Isolere's mission is to increase global access to life-changing therapeutics and vaccines by offering novel purification reagents to alleviate manufacturing bottlenecks. The IsoTag™ reagents reimagine bioprocessing by combining target specific affinity ligands with phase separating biopolymers. The Affinity Liquid Phase Separation (ALPS) allows target biologics to be separated on the basis of affinity and size in a single process and can be implemented in a variety of techniques including microfiltration TFF and centrifugation processes. Isolere is currently developing purification solutions for adeno-associated virus (AAV), lentivirus (LV), adenovirus (AdV) and mRNA. Visit our website to learn more! Isolere Bio was acquired by Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, in February 2023.
| Website | https://www.isolerebio.com/ |
| Employees | 25 (20 on RocketReach) |
| Founded | 2017 |
| Address | RTP, Durham, North Carolina 27709, US |
| Phone | +1 719-322-4394 |
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Health Care, Therapeutics |
| Keywords | Vaccine Manufacturing, Biotechnology Reagents, Protein Purification, Pharmaceutical Manufacturing, Downstream Processing, Purification Technology, Biopharmaceutical Manufacturing, Reagents And Chemicals, Life Science Reagents, Pharmaceutical Reagents, Drug Manufacturing, Bioprocessing Technology, Manufacturing Solutions, Process Optimization, Drug Development |
| Competitors | Roche, Thermo Fisher Scientific, Bristol Myers Squibb, Genentech, Regeneron, Lonza, STEMCELL Technologies, bluebird bio, Cellular Dynamics International, Celyad Oncology +37 more (view full list) |
Looking for a particular Isolere Bio employee's phone or email?
Nikki Votaw is the Associate Director, R and D of Isolere Bio.
20 people are employed at Isolere Bio.
Isolere Bio is based in Durham, North Carolina.